Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules, 65315-65317 [2013-25710]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 211 / Thursday, October 31, 2013 / Notices
branded product for a period of 180
days.
mstockstill on DSK4VPTVN1PROD with NOTICES
Entry Into the Relevant Markets
Entry Into the markets for generic
Femcon FE, Lo Loestrin 24 and its
generic equivalents, Loestrin 24 FE and
its generic equivalents, and Atelvia and
its generic equivalents would not be
timely, likely, or sufficient in
magnitude, character, and scope to deter
or counteract the anticompetitive effects
of the acquisition. De novo entry would
not take place in a timely manner
because the combination of drug
development times and FDA approval
requirements would delay entry by at
least two years. Even companies for
which the FDA approval process is well
underway face additional barriers,
including Hatch-Waxman regulatory
exclusivity and pending patent
litigation, that prevent them from
entering these markets in time to deter
the price increases that would occur
after consummation of the Proposed
Acquisition.
The Anticompetitive Effects of the
Acquisition
The Proposed Acquisition would
cause significant anticompetitive harm
to consumers in the U.S. markets for
generic Femcon FE, Lo Loestrin 24 and
its generic equivalents, Lo Loestrin FE
and its generic equivalents, and Atelvia
and its generic equivalents. The
Proposed Acquisition would eliminate
the current competition between the
only two significant suppliers of generic
Femcon FE, leading to significantly
higher prices for this drug. The
acquisition may also delay the onset of
beneficial generic competition in the
markets for Loestrin 24 FE, Lo Loestrin
FE, and Atelvia. Evidence, including
information regarding the status of the
FDA approval process for potential
suppliers of generic Loestrin 24 FE,
suggests that Actavis will be the first
generic supplier to compete against
Warner Chilcott’s branded product.
Moreover, no other generic supplier is
likely to enter the market for a
significant period of time. Thus, the
combined firm would likely delay the
entry of Actavis’s generic version of
Loestrin 24 FE or, at a minimum, cause
Actavis’s generic drug to compete less
vigorously against Warner Chilcott’s
branded product, resulting in higher
prices for consumers. Similarly, in the
markets for Lo Loestrin FE and Atelvia,
VerDate Mar<15>2010
19:21 Oct 30, 2013
Jkt 232001
Actavis may be the first and only
generic competitor to Warner Chilcott’s
branded products for a significant
period absent the Proposed Acquisition.
By eliminating this potential
competition between Warner Chilcott
and Actavis in each of these markets,
the Proposed Acquisition would harm
U.S. consumers by substantially
increasing the likelihood of higher postacquisition prices for Lo Loestrin FE
and Atelvia.
The Proposed Consent Agreement
The proposed Consent Agreement
effectively remedies the Proposed
Acquisition’s anticompetitive effects in
the relevant markets by requiring
Actavis to divest to Amneal certain
rights and assets related to generic
Femcon FE, generic Loestrin 24 FE,
generic Lo Loestrin FE, and generic
Atelvia no later than ten days after
consummating the acquisition. In
addition, the Consent Agreement
requires Actavis to enter into a supply
agreement to provide Amneal with
generic versions of the Femcon FE and
Loestrin 24 FE products to sell in the
United States for up to four years.
Amneal is a New Jersey-based generic
pharmaceutical company that currently
markets 65 products and maintains an
active product development pipeline.
With its experience in generic markets,
Amneal is well positioned to replicate
the competition that would otherwise be
lost as a result of the Proposed
Acquisition.
If the Commission determines that
Amneal is not an acceptable acquirer of
the assets to be divested, or that the
manner of the divestitures is not
acceptable, Actavis must unwind the
sale to Amneal and divest the products
within six months of the date the Order
becomes final, to a Commissionapproved acquirer. If Actavis fails to
divest the products as required, the
Commission may appoint a trustee to
divest the products.
The proposed Consent Agreement
contains several provisions to help
ensure that the divestitures are
successful. The Order requires Actavis
to maintain the economic viability,
marketability, and competitiveness of
the divestiture products until such time
as they are transferred to Amneal or
another Commission-approved acquirer.
Actavis must also transfer the
manufacturing technology for the
divestiture products to Amneal and
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
65315
supply Amneal with the generic
Femcon FE and Loestrin 24 FE products
during the transition period. In
addition, the Consent Agreement
requires Actavis to relinquish any claim
to marketing exclusivity for generic Lo
Loestrin FE and Atelvia products to
ensure that the incentives of the
companies currently leading the patent
litigations relating to those products do
not change.
The purpose of this analysis is to
facilitate public comment on the
proposed Consent Agreement, and it is
not intended to constitute an official
interpretation of the proposed Order or
to modify its terms in any way.
By direction of the Commission.
Donald S. Clark
Secretary.
[FR Doc. 2013–25847 Filed 10–30–13; 8:45 am]
BILLING CODE 6750–01–P
FEDERAL TRADE COMMISSION
Granting of Request for Early
Termination of the Waiting Period
Under the Premerger Notification
Rules
Section 7A of the Clayton Act, 15
U.S.C. 18a, as added by Title II of the
Hart-Scott-Rodino Antitrust
Improvements Act of 1976, requires
persons contemplating certain mergers
or acquisitions to give the Federal Trade
Commission and the Assistant Attorney
General advance notice and to wait
designated periods before
consummation of such plans. Section
7A(b)(2) of the Act permits the agencies,
in individual cases, to terminate this
waiting period prior to its expiration
and requires that notice of this action be
published in the Federal Register.
The following transactions were
granted early termination—on the dates
indicated—of the waiting period
provided by law and the premerger
notification rules. The listing for each
transaction includes the transaction
number and the parties to the
transaction. The grants were made by
the Federal Trade Commission and the
Assistant Attorney General for the
Antitrust Division of the Department of
Justice. Neither agency intends to take
any action with respect to these
proposed acquisitions during the
applicable waiting period.
E:\FR\FM\31OCN1.SGM
31OCN1
65316
Federal Register / Vol. 78, No. 211 / Thursday, October 31, 2013 / Notices
EARLY TERMINATIONS GRANTED
[September 1, 2013 thru September 30, 2013]
09/03/2013
20131084
20131136
20131205
20131211
20131212
......
......
......
......
......
G
G
G
G
G
Boston Scientific Corporation; C.R. Bard, Inc.; Boston Scientific Corporation.
Cisco Systems, Inc.; Sourcefire, Inc.; Cisco Systems, Inc.
David H. Murdock; Dole Food Company, Inc.; David H. Murdock.
Ronald O. Perelman; Beauty Care Professional Products Participations, S.A.; Ronald O. Perelman.
Rockwool International A/S; CMC Family Holdings LLC; Rockwool International A/S.
09/04/2013
20131227 ......
G
Pianissimo Holdings Corp.; Steinway Musical Instruments, Inc.; Pianissimo Holdings Corp.
09/05/2013
20131180 ......
G
20131181 ......
G
20131187 ......
20131223 ......
G
G
Trian Partners Strategic Investment Fund, L.P.; E.I. du Pont de Nemours and Company; Trian Partners Strategic Investment Fund, L.P.
Trian Partners Strategic Investment Fund II, L.P.; E.I. du Pont de Nemours and Company; Trian Partners Strategic Investment Fund II, L.P.
CareGroup, Inc.; The Jordan Health Systems, Inc.; CareGroup, Inc.
Parametric Sound Corporation; VTB Holdings, Inc.; Parametric Sound Corporation.
09/09/2013
20131225
20131226
20131229
20131234
20131240
20131243
......
......
......
......
......
......
G
G
G
G
G
G
Jeffrey P. Bezos; The Washington Post Company; Jeffrey P. Bezos.
Crestview Partners II (Outbound), L.P.; Sterling Group Partners III (AIV), L.P.; Crestview Partners II (Outbound), L.P.
Allied Motion Technologies Inc.; Safran SA; Allied Motion Technologies Inc.
Crystal T, LLC; Onex Partners II LP; Crystal T, LLC.
ONEOK Partners, L.P.; Merit Energy Company, LLC; ONEOK Partners, L.P.
CH Holding L.P.; Bend Research, Inc.; CH Holding L.P.
09/10/2013
20131238 ......
20131242 ......
G
G
Francisco Partners III, L.P.; Austin Ventures VIII, L.P.; Francisco Partners III, L.P.
Atlas Copco AB; Edwards Group Limited; Atlas Copco AB.
09/11/2013
20131192 ......
20131246 ......
G
G
Actelion Ltd.; Ceptaris Therapeutics, Inc.; Actelion Ltd.
loanDepot.com, LLC; imortgage.com, Inc.; loanDepot.com, LLC.
09/12/2013
20131197
20131198
20131228
20131247
20131248
......
......
......
......
......
G
G
G
G
G
Perrigo Company; Elan Corporation, plc; Perrigo Company.
Elan Corporation plc; Perrigo Company; Elan Corporation plc.
KKR European Fund III, Limited Partnership; RigNet, Inc.; KKR European Fund III, Limited Partnership.
Nabors Industries Ltd.; Richard W. Wurster; Nabors Industries Ltd.
Nabors Industries Ltd.; Danny R. Shaffer; Nabors Industries Ltd.
09/13/2013
20130504 ......
20131206 ......
20131267 ......
G
G
G
Honeywell International Inc.; Intermec, Inc.; Honeywell International Inc.
C.R. Bard, Inc.; Medafor, Inc.; C.R. Bard, Inc.
John S. Chiorando; Personal Communications Devices Holdings LLC; John S. Chiorando.
09/16/2013
20131224 ......
20131262 ......
G
G
Partners Limited; Entergy Corporation; Partners Limited.
Sterling Group Partners III, L.P.; Century Park Capital Partners II, L.P.; Sterling Group Partners III, L.P.
09/18/2013
20131263 ......
G
Amgen Inc.; Onyx Pharmaceuticals, Inc.; Amgen Inc.
mstockstill on DSK4VPTVN1PROD with NOTICES
09/19/2013
20131254 ......
G
The Madison Square Garden Company; Azoff MSG Entertainment LLC; The Madison Square Garden Company.
09/20/2013
20131273
20131276
20131284
20131285
......
......
......
......
VerDate Mar<15>2010
G
G
G
G
Providence Equity Partners VII–A L.P.; Shamrock Capital Growth Fund III, L.P.; Providence Equity Partners VII–A L.P.
MDCP VI–A Global Investments LP; Madison Dearborn Capital Partners VI–A, L.P.; MDCP VI–A Global Investments LP.
2349468 Ontario Limited; Ryan A. Busbice; 2349468 Ontario Limited.
Morgan McCague; Ryan A. Busbice; Morgan McCague.
19:21 Oct 30, 2013
Jkt 232001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\31OCN1.SGM
31OCN1
Federal Register / Vol. 78, No. 211 / Thursday, October 31, 2013 / Notices
65317
EARLY TERMINATIONS GRANTED—Continued
[September 1, 2013 thru September 30, 2013]
20131287 ......
G
20131288 ......
G
Centerbridge Capital Partners II (Cayman), L.P.; GenNx360 Capital Partners, L.P.; Centerbridge Capital Partners II (Cayman), L.P.
Magellan Health Services, Inc.; Mark V. Mertel and Miriam Mertel; Magellan Health Services, Inc.
09/23/2013
20131217 ......
G
Verizon Communications Inc.; Telephone and Data Systems, Inc. Voting Trust; Verizon Communications Inc.
09/24/2013
20131244
20131259
20131271
20131279
20131281
20131291
20131295
......
......
......
......
......
......
......
G
G
G
G
G
G
G
Arrow Electronics, Inc.; CSS Computer Security Solutions Holding GmbH; Arrow Electronics, Inc.
AstraZeneca PLC; Amplimmune, Inc.; AstraZeneca PLC.
Cisco Systems, Inc.; Whiptail Technologies, Inc.; Cisco Systems, Inc.
Calfrac Well Services Ltd.; Mission Investment Partners, LLC; Calfrac Well Services Ltd.
Oasis Petroleum Inc.; Dawn Arnall; Oasis Petroleum Inc.
Heico Corporation; Lucix Corporation; Heico Corporation.
NM Mariposa Holdings, Inc.; Newton Holding, LLC; NM Mariposa Holdings, Inc.
09/25/2013
20131253 ......
20131280 ......
G
G
Capital One Financial Corporation; Beech Street Capital Holdings, LLC; Capital One Financial.
Corporation VEPF IV AIV VI, L.P.; QUALCOMM Incorporated; VEPF IV AIV VI, L.P.
09/27/2013
20130759
20130959
20130960
20131255
20131275
20131299
20131306
20131307
20131308
20131309
20131318
......
......
......
......
......
......
......
......
......
......
......
G
S
S
G
G
G
G
G
G
G
G
Mylan Inc.; Strides Arcolab Limited; Mylan Inc.
Actavis, Inc.; Warner Chilcott plc; Actavis, Inc.
Warner Chilcott plc; Actavis, Inc.; Warner Chilcott plc.
FR XII Charlie AIV, L.P.; Utility Services Associates, Inc.; FR XII Charlie AIV, L.P.
LS Power Equity Partners II, L.P.; FirstEnergy Corp.; LS Power Equity Partners II, L.P.
Koch Industries, Inc.; Molex Incorporated; Koch Industries, Inc.
The Resolute Fund II, L.P.; Harbour Group Investments V, L.P.; The Resolute Fund II, L.P.
Anthony C. and Alice C. Cibilich; The Resolute Fund II Maritime Partnership, L.P.; Anthony C. and Alice C. Cibilich.
Twitter, Inc.; MoPub Inc.; Twitter, Inc.
Aurora Resurgence Fund II L.P.; Aurora Resurgence Fund (C) L.P.; Aurora Resurgence Fund II L.P.
Clayton, Dubilier & Rice Fund IX, L.P.; FR XI Offshore AIV, L.P.; Clayton, Dubilier & Rice Fund IX, L.P.
09/30/2013
20131174 ......
20131264 ......
G
G
20131268 ......
20131269 ......
20131301 ......
G
G
G
20131303 ......
20131343 ......
G
G
Centrica plc; Hess Corporation; Centrica plc.
University of Maryland Medical System, Corp.; Upper Chesapeake Health System, Inc.; University of Maryland Medical
System, Corp.
Third Point Ultra, Ltd.; Sotheby’s; Third Point Ultra, Ltd.
Third Point Offshore Fund, Ltd.; Sotheby’s; Third Point Offshore Fund, Ltd.
The Resolute Fund II Maritime Partnership, L.P.; Abdon Callais Offshore, LLC; The Resolute Fund II Maritime Partnership,
L.P.
EnerSys; Purcell Systems, Inc.; EnerSys.
Packaging Corporation of America; Boise Inc.; Packaging Corporation of America.
FOR FURTHER INFORMATION CONTACT:
Renee Chapman, Contact
Representative, or Theresa Kingsberry
Legal, Assistant. Federal Trade
Commission Premerger, Notification
Office Bureau of Competition, Room H–
303, Washington, DC 20580, (202) 326–
3100.
mstockstill on DSK4VPTVN1PROD with NOTICES
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2013–25710 Filed 10–30–13; 8:45 am]
BILLING CODE 6750–01–P
VerDate Mar<15>2010
19:21 Oct 30, 2013
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Committee on Vital and Health
Statistics: Meeting Standards
Subcommittee
Pursuant to the Federal Advisory
Committee Act, the Department of
Health and Human Services (HHS)
announces the following advisory
committee meeting.
Name: National Committee on Vital and
Health Statistics (NCVHS) Subcommittee on
Standards.
Time and Date: November 12, 2013 8:30
a.m.–5:30 p.m. EST.
Place: Centers for Disease Control and
Prevention, National Center for Health
Statistics, 3311 Toledo Road, Auditorium B
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
& C, Hyattsville, Maryland 20782, (301) 458–
4524.
Status: Open.
Purpose: The purpose of this hearing is to
gather industry input on the state of health
data standards used by public health and
population health programs, and the scope of
the meeting will include standards used for
electronic exchange of information between
public health and external stakeholders. This
includes standards for data coding,
document-type standards, message content,
structure and format standards, transport,
vocabulary and terminology, and data
management standards across various public
health functions and activities including but
not limited to vital statistics, biosurveillance, syndromic surveillance,
screening, immunizations, public health
laboratory, environmental health, and public
health/population health analytics. Coding
and classification systems for certain core
public health data elements will be included.
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 78, Number 211 (Thursday, October 31, 2013)]
[Notices]
[Pages 65315-65317]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25710]
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
Granting of Request for Early Termination of the Waiting Period
Under the Premerger Notification Rules
Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II
of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires
persons contemplating certain mergers or acquisitions to give the
Federal Trade Commission and the Assistant Attorney General advance
notice and to wait designated periods before consummation of such
plans. Section 7A(b)(2) of the Act permits the agencies, in individual
cases, to terminate this waiting period prior to its expiration and
requires that notice of this action be published in the Federal
Register.
The following transactions were granted early termination--on the
dates indicated--of the waiting period provided by law and the
premerger notification rules. The listing for each transaction includes
the transaction number and the parties to the transaction. The grants
were made by the Federal Trade Commission and the Assistant Attorney
General for the Antitrust Division of the Department of Justice.
Neither agency intends to take any action with respect to these
proposed acquisitions during the applicable waiting period.
[[Page 65316]]
Early Terminations Granted
[September 1, 2013 thru September 30, 2013]
------------------------------------------------------------------------
------------------------------------------------------------------------
09/03/2013
------------------------------------------------------------------------
20131084.................. G Boston Scientific
Corporation; C.R. Bard,
Inc.; Boston Scientific
Corporation.
20131136.................. G Cisco Systems, Inc.;
Sourcefire, Inc.; Cisco
Systems, Inc.
20131205.................. G David H. Murdock; Dole Food
Company, Inc.; David H.
Murdock.
20131211.................. G Ronald O. Perelman; Beauty
Care Professional Products
Participations, S.A.; Ronald
O. Perelman.
20131212.................. G Rockwool International A/S;
CMC Family Holdings LLC;
Rockwool International A/S.
------------------------------------------------------------------------
09/04/2013
------------------------------------------------------------------------
20131227.................. G Pianissimo Holdings Corp.;
Steinway Musical
Instruments, Inc.;
Pianissimo Holdings Corp.
------------------------------------------------------------------------
09/05/2013
------------------------------------------------------------------------
20131180.................. G Trian Partners Strategic
Investment Fund, L.P.; E.I.
du Pont de Nemours and
Company; Trian Partners
Strategic Investment Fund,
L.P.
20131181.................. G Trian Partners Strategic
Investment Fund II, L.P.;
E.I. du Pont de Nemours and
Company; Trian Partners
Strategic Investment Fund
II, L.P.
20131187.................. G CareGroup, Inc.; The Jordan
Health Systems, Inc.;
CareGroup, Inc.
20131223.................. G Parametric Sound Corporation;
VTB Holdings, Inc.;
Parametric Sound
Corporation.
------------------------------------------------------------------------
09/09/2013
------------------------------------------------------------------------
20131225.................. G Jeffrey P. Bezos; The
Washington Post Company;
Jeffrey P. Bezos.
20131226.................. G Crestview Partners II
(Outbound), L.P.; Sterling
Group Partners III (AIV),
L.P.; Crestview Partners II
(Outbound), L.P.
20131229.................. G Allied Motion Technologies
Inc.; Safran SA; Allied
Motion Technologies Inc.
20131234.................. G Crystal T, LLC; Onex Partners
II LP; Crystal T, LLC.
20131240.................. G ONEOK Partners, L.P.; Merit
Energy Company, LLC; ONEOK
Partners, L.P.
20131243.................. G CH Holding L.P.; Bend
Research, Inc.; CH Holding
L.P.
------------------------------------------------------------------------
09/10/2013
------------------------------------------------------------------------
20131238.................. G Francisco Partners III, L.P.;
Austin Ventures VIII, L.P.;
Francisco Partners III, L.P.
20131242.................. G Atlas Copco AB; Edwards Group
Limited; Atlas Copco AB.
------------------------------------------------------------------------
09/11/2013
------------------------------------------------------------------------
20131192.................. G Actelion Ltd.; Ceptaris
Therapeutics, Inc.; Actelion
Ltd.
20131246.................. G loanDepot.com, LLC;
imortgage.com, Inc.;
loanDepot.com, LLC.
------------------------------------------------------------------------
09/12/2013
------------------------------------------------------------------------
20131197.................. G Perrigo Company; Elan
Corporation, plc; Perrigo
Company.
20131198.................. G Elan Corporation plc; Perrigo
Company; Elan Corporation
plc.
20131228.................. G KKR European Fund III,
Limited Partnership; RigNet,
Inc.; KKR European Fund III,
Limited Partnership.
20131247.................. G Nabors Industries Ltd.;
Richard W. Wurster; Nabors
Industries Ltd.
20131248.................. G Nabors Industries Ltd.; Danny
R. Shaffer; Nabors
Industries Ltd.
------------------------------------------------------------------------
09/13/2013
------------------------------------------------------------------------
20130504.................. G Honeywell International Inc.;
Intermec, Inc.; Honeywell
International Inc.
20131206.................. G C.R. Bard, Inc.; Medafor,
Inc.; C.R. Bard, Inc.
20131267.................. G John S. Chiorando; Personal
Communications Devices
Holdings LLC; John S.
Chiorando.
------------------------------------------------------------------------
09/16/2013
------------------------------------------------------------------------
20131224.................. G Partners Limited; Entergy
Corporation; Partners
Limited.
20131262.................. G Sterling Group Partners III,
L.P.; Century Park Capital
Partners II, L.P.; Sterling
Group Partners III, L.P.
------------------------------------------------------------------------
09/18/2013
------------------------------------------------------------------------
20131263.................. G Amgen Inc.; Onyx
Pharmaceuticals, Inc.; Amgen
Inc.
------------------------------------------------------------------------
09/19/2013
------------------------------------------------------------------------
20131254.................. G The Madison Square Garden
Company; Azoff MSG
Entertainment LLC; The
Madison Square Garden
Company.
------------------------------------------------------------------------
09/20/2013
------------------------------------------------------------------------
20131273.................. G Providence Equity Partners
VII-A L.P.; Shamrock Capital
Growth Fund III, L.P.;
Providence Equity Partners
VII-A L.P.
20131276.................. G MDCP VI-A Global Investments
LP; Madison Dearborn Capital
Partners VI-A, L.P.; MDCP VI-
A Global Investments LP.
20131284.................. G 2349468 Ontario Limited; Ryan
A. Busbice; 2349468 Ontario
Limited.
20131285.................. G Morgan McCague; Ryan A.
Busbice; Morgan McCague.
[[Page 65317]]
20131287.................. G Centerbridge Capital Partners
II (Cayman), L.P.; GenNx360
Capital Partners, L.P.;
Centerbridge Capital
Partners II (Cayman), L.P.
20131288.................. G Magellan Health Services,
Inc.; Mark V. Mertel and
Miriam Mertel; Magellan
Health Services, Inc.
------------------------------------------------------------------------
09/23/2013
------------------------------------------------------------------------
20131217.................. G Verizon Communications Inc.;
Telephone and Data Systems,
Inc. Voting Trust; Verizon
Communications Inc.
------------------------------------------------------------------------
09/24/2013
------------------------------------------------------------------------
20131244.................. G Arrow Electronics, Inc.; CSS
Computer Security Solutions
Holding GmbH; Arrow
Electronics, Inc.
20131259.................. G AstraZeneca PLC; Amplimmune,
Inc.; AstraZeneca PLC.
20131271.................. G Cisco Systems, Inc.; Whiptail
Technologies, Inc.; Cisco
Systems, Inc.
20131279.................. G Calfrac Well Services Ltd.;
Mission Investment Partners,
LLC; Calfrac Well Services
Ltd.
20131281.................. G Oasis Petroleum Inc.; Dawn
Arnall; Oasis Petroleum Inc.
20131291.................. G Heico Corporation; Lucix
Corporation; Heico
Corporation.
20131295.................. G NM Mariposa Holdings, Inc.;
Newton Holding, LLC; NM
Mariposa Holdings, Inc.
------------------------------------------------------------------------
09/25/2013
------------------------------------------------------------------------
20131253.................. G Capital One Financial
Corporation; Beech Street
Capital Holdings, LLC;
Capital One Financial.
20131280.................. G Corporation VEPF IV AIV VI,
L.P.; QUALCOMM Incorporated;
VEPF IV AIV VI, L.P.
------------------------------------------------------------------------
09/27/2013
------------------------------------------------------------------------
20130759.................. G Mylan Inc.; Strides Arcolab
Limited; Mylan Inc.
20130959.................. S Actavis, Inc.; Warner
Chilcott plc; Actavis, Inc.
20130960.................. S Warner Chilcott plc; Actavis,
Inc.; Warner Chilcott plc.
20131255.................. G FR XII Charlie AIV, L.P.;
Utility Services Associates,
Inc.; FR XII Charlie AIV,
L.P.
20131275.................. G LS Power Equity Partners II,
L.P.; FirstEnergy Corp.; LS
Power Equity Partners II,
L.P.
20131299.................. G Koch Industries, Inc.; Molex
Incorporated; Koch
Industries, Inc.
20131306.................. G The Resolute Fund II, L.P.;
Harbour Group Investments V,
L.P.; The Resolute Fund II,
L.P.
20131307.................. G Anthony C. and Alice C.
Cibilich; The Resolute Fund
II Maritime Partnership,
L.P.; Anthony C. and Alice
C. Cibilich.
20131308.................. G Twitter, Inc.; MoPub Inc.;
Twitter, Inc.
20131309.................. G Aurora Resurgence Fund II
L.P.; Aurora Resurgence Fund
(C) L.P.; Aurora Resurgence
Fund II L.P.
20131318.................. G Clayton, Dubilier & Rice Fund
IX, L.P.; FR XI Offshore
AIV, L.P.; Clayton, Dubilier
& Rice Fund IX, L.P.
------------------------------------------------------------------------
09/30/2013
------------------------------------------------------------------------
20131174.................. G Centrica plc; Hess
Corporation; Centrica plc.
20131264.................. G University of Maryland
Medical System, Corp.; Upper
Chesapeake Health System,
Inc.; University of Maryland
Medical System, Corp.
20131268.................. G Third Point Ultra, Ltd.;
Sotheby's; Third Point
Ultra, Ltd.
20131269.................. G Third Point Offshore Fund,
Ltd.; Sotheby's; Third Point
Offshore Fund, Ltd.
20131301.................. G The Resolute Fund II Maritime
Partnership, L.P.; Abdon
Callais Offshore, LLC; The
Resolute Fund II Maritime
Partnership, L.P.
20131303.................. G EnerSys; Purcell Systems,
Inc.; EnerSys.
20131343.................. G Packaging Corporation of
America; Boise Inc.;
Packaging Corporation of
America.
------------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: Renee Chapman, Contact Representative,
or Theresa Kingsberry Legal, Assistant. Federal Trade Commission
Premerger, Notification Office Bureau of Competition, Room H-303,
Washington, DC 20580, (202) 326-3100.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2013-25710 Filed 10-30-13; 8:45 am]
BILLING CODE 6750-01-P
